1.
Lebwohl M, Warren RB, Imafuku S, Bagel J, Armstrong AW, Passeron T, Banerjee S, Kisa RM, Vritzali E, Colombo MJ, Scharnitz T, Hoyt K, Tha├ži D, Blauvelt A. Deucravacitinib Long-Term Efficacy in Week 16 Placebo Crossovers: 3-year Results from the POETYK PSO Program. J of Skin [Internet]. 2024Mar.18 [cited 2024May23];8(2):s365. Available from: https://jofskin.org/index.php/skin/article/view/2672